Skip to main content
TipRanks
Go Ultimate75% OFF

Geoffrey Dunbar Insider Profile

4 Followers

Geoffrey Dunbar, SVP, Clin. Dev. & Reg. Affairs at Gyre Therapeutics, holds 1.15K shares in Gyre Therapeutics (Ticker: GYRE).

Geoffrey Dunbar's Trading History

GYRE
Gyre Therapeutics
Dec 21, 2010SVP, Clin. Dev. & Reg. AffairsUninformative Sell285.86K$5.06K
GYRE
Insider Shares: 1.15K (0.01%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 21, 2010Uninformative Sell$285.86K10,982$26.02―
Dec 20, 2010Uninformative Sell$5.03K200$25.15―
Dec 10, 2010Informative Sell$255.15K11,250$22.68+68.80%
Nov 09, 2010Uninformative Sell$17.51K700$25.01―
Nov 05, 2010Uninformative Sell$219.76K8,770$25.05―

You May Also Like

Geoffrey Dunbar insider profile FAQ

What is the percentage of profitable transactions made by Geoffrey Dunbar?
The percentage of profitable transactions made by Geoffrey Dunbar is 50%.
What is the average return per transaction made by Geoffrey Dunbar?
The average return per transaction made by Geoffrey Dunbar is 26.50%.
What stocks does Geoffrey Dunbar hold?
Geoffrey Dunbar holds: GYRE stocks.
What was Geoffrey Dunbar’s latest transaction?
Geoffrey Dunbar’s latest transaction was an Uninformative Sell of $285.86K.
What was Geoffrey Dunbar's most profitable transaction?
Geoffrey Dunbar’s most profitable transaction was an Informative Sell of GYRE stock on December 10, 2010. The return on the trade was 68.80%.
What is Geoffrey Dunbar's role in Gyre Therapeutics?
Geoffrey Dunbar's role in Gyre Therapeutics is SVP, Clin. Dev. & Reg. Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.